Preprint · CC0
via OpenAlex
Enhancing bone marrow-derived mesenchymal stem cell therapeutic potential through mTOR inhibition
Lisa Stukenborg, Christian Sell
iDEA - Drexel University Institutional Repository · 2022
Epigenetic alterations
Deregulated nutrient-sensing
Cellular senescence
Stem-cell exhaustion
Stem-cell therapy
Rapamycin / mTOR inhibition
Human
Abstract
Despite our best efforts to avoid growing older, aging is an inevitable phenomenon that affects all living organisms. The aging process results from normal biological processes that are necessary for maintaining cellular homeostasis, including protein translation and regulation, lipid and nucleotide biosynthesis, nuclear maintenance and chromatin modifications. Over time, cells begin to accumulate damage, enter a unique state known as senescence(definition), disrupting their functionality and thereby contributing to a reduction in organismal lifespan. One of the hallmarks of senescence is an irreversible arrest of the cell cycle resulting in cells which are no longer able to proliferate. Since its discovery, senescence in somatic cells has been well defined, but there are still limitations of our knowledge regarding senescence in stem cells, however, a progressive decline in adult stem cell function is a feature of aged tissues and contributes to multiple age-related diseases. Of particular interest are bone marrow mesenchymal stem cells, also known as bone marrow stromal cells (BMSCs), which are multipotent and have significant therapeutic potential. In this study, we aimed to understand senescence in human bone-marrow mesenchymal stem cells. In addition, we examined the impact of inhibiting the mechanistic/mammalian target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) (mTOR), using rapamycin, on senescence in BMSCs. We found that stem cells undergo senescence similarly to somatic cells, but also have unique features that have not yet been reported. Due to the implications of senescence in various diseases, this research helps shed light on the role of stem cells during organismal aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.17918/00001098
- Canonical
- link ↗
- Fetched
- 2026-11-10 MST
Cite this
APA
Stukenborg, L., & Sell, C. (2022). Enhancing bone marrow-derived mesenchymal stem cell therapeutic potential through mTOR inhibition. <em>iDEA - Drexel University Institutional Repository</em>. https://doi.org/10.17918/00001098
Vancouver
Stukenborg L, Sell C. Enhancing bone marrow-derived mesenchymal stem cell therapeutic potential through mTOR inhibition. iDEA - Drexel University Institutional Repository. 2022. doi:10.17918/00001098.
BibTeX
@unpublished{lisa2022Enhanc,
title = {Enhancing bone marrow-derived mesenchymal stem cell therapeutic potential through mTOR inhibition},
author = {Lisa Stukenborg and Christian Sell},
journal = {iDEA - Drexel University Institutional Repository},
year = {2022},
doi = {10.17918/00001098},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Stem cell reviews and reports 2026
Citation only
Stem Cells in Aging and Anti-Aging.
Frontiers in Cell and Developmental Biology 2020
Open access · CC-BY
Senescence in Mesenchymal Stem Cells: Functional Alterations, Molecular Mechanisms, and Rejuvenation Strategies
bioRxiv (Cold Spring Harbor Laboratory) 2024
Preprint · OA
Mechanical Rejuvenation of Mesenchymal Stem Cells from Aged Patients
International Journal of Molecular Medicine 2017
Citation only
Senescence of mesenchymal stem cells (Review)
Advances in Therapy 2020
Open access · CC-BY
Cellular Senescence as a Therapeutic Target for Age-Related Diseases: A Review
Aging 2011
Preprint · CC-BY